Metraipolis › archive › dc_418ffb66c02b

The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients — Europe PMC PMID:41642747

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41642747
DOI
10.1158/2767-9764.crc-25-0660
License (as archived)
solo-consultazione
Archived
2026-11-06T09:09:28.396Z
SHA-256 of the archived text
aaed7b156c8ddb3ab443fcdcc97b2c16a3ed3074608acd0b7452520a189064e9
Stable URL of this page
https://metraipolis.com/documento/dc_418ffb66c02b

How to cite

The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients — Europe PMC PMID:41642747 — Europe PMC (en), https://europepmc.org/article/MED/41642747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_418ffb66c02b (Metraipolis archive dc_418ffb66c02b, sha256 aaed7b156c8ddb3ab443fcdcc97b2c16a3ed3074608acd0b7452520a189064e9)
BibTeX
@misc{dc418ffb66c02b,
  title = {The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients — Europe PMC PMID:41642747},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41642747},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_418ffb66c02b; sha256 aaed7b156c8ddb3ab443fcdcc97b2c16a3ed3074608acd0b7452520a189064e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41642747. Agents can read the archived copy with the MCP tool read_document.